Extending evidence-based medicine
Edited by: Prof Trisha Greenhalgh
The science of evidence-based medicine (EBM) is more than 20 years old. Unsurprisingly the movement has produced both an established orthodoxy and dissenting voices. This series of papers, whose authors include both ‘orthodox’ and ‘dissenting’ perspectives, considers how EBM might be extended beyond the epidemiological focus of its founding fathers. We invite comments from readers and anticipate that this series will provoke an important contemporary debate on what EBM is and what it should become.
Collection published in: Trials, BMC Medicine, BMC Medical Ethics.
The importance of values in evidence-based medicineEvidence-based medicine (EBM) has always required integration of patient values with ‘best’ clinical evidence. It is widely recognized that scientific practices and discoveries, including those of EBM, are val...BMC Medical Ethics 2015 16:69Published on: 12 October 2015
Trustworthy guidelines – excellent; customized care tools – even betterThe ability to do online searches for health information has led to concerns that patients find the results confusing and that they often lead to expectations for treatments that have little supportive evidenc...BMC Medicine 2015 13:199Published on: 1 September 2015
Six ‘biases’ against patients and carers in evidence-based medicineEvidence-based medicine (EBM) is maturing from its early focus on epidemiology to embrace a wider range of disciplines and methodologies. At the heart of EBM is the patient, whose informed choices have long be...BMC Medicine 2015 13:200Published on: 1 September 2015
Randomised trials in context: practical problems and social aspects of evidence-based medicine and policyRandomised trials can provide excellent evidence of treatment benefit in medicine. Over the last 50 years, they have been cemented in the regulatory requirements for the approval of new treatments. Randomised ...Trials 2015 16:394Published on: 1 September 2015
No hay comentarios:
Publicar un comentario